đź©ş CPT 51702 - Insertion of Temporary Indwelling Bladder Catheter; Simple (eg, Foley)
Last Updated: September 2026
Status: 2025 Medicare Fee Schedule Compliant
Specialty Tags: urology emergency-medicine internal-medicine hospitalist specialty/urology
Use this CPT, 51702, when inserting a standard Foley catheter that is placed without difficulty — no coudé, no guidewire, no fluoroscopy, no extra attempts.
Quick Reference
| Element | Details |
|---|---|
| Code | 51702 |
| Code Type | CPT (Current Procedural Terminology) |
| Descriptor | Insertion of Temporary Indwelling Bladder Catheter; Simple (eg, Foley) |
| Procedure Type | Non-endoscopic, transurethral bladder catheterization |
| Global Period | 000 (Zero-Day) |
| Work RVU (2026) | 0.49 |
| Bilateral | No (single structure) |
| Typical Setting | Office, ED, Inpatient, Outpatient |
đź“‹ Short Definition
CPT 51702 reports the straightforward insertion of a temporary indwelling (Foley) bladder catheter via the urethra into the bladder, where no additional technique, equipment, or skill beyond routine placement is required.
Long Definition
CPT 51702 represents a simple bedside Foley catheter insertion in which the catheter is passed through the urethra into the bladder, the balloon is inflated, and the catheter is secured — all without encountering anatomic difficulty or requiring adjunctive tools.
What makes it “simple” (code-qualifying criteria)
- Catheter advanced in one or two attempts without deviation
- No coudé-tip catheter needed
- No guidewire, cystoscope, or fluoroscopy used
- No altered anatomy (e.g., prior prostatectomy, urethral stricture, post-radiation changes)
- No fractured catheter or balloon encountered
- No need for a urologist or specialist to perform
What would escalate this to 51703 (complicated)
- Use of a coudé (curved-tip) catheter
- Guidewire-assisted placement
- Cystoscopy or fluoroscopy required
- Multiple failed attempts before successful placement
- Altered anatomy (post-prostatectomy, stricture, diverticulum)
- Fractured catheter or balloon requiring retrieval/exchange
What this is NOT
| Not this… | Correct code |
|---|---|
| Intermittent/straight catheterization (catheter removed after use) | 51701 |
| Complicated indwelling catheter (extra technique needed) | 51703 |
| Cystoscopy (endoscopic visualization of bladder) | 52000 |
| Ureteral catheterization / retrograde pyelogram | 52005 |
| Suprapubic catheter insertion | 52295 / 52290 |
| Catheter exchange (same type, same route) | Not separately reportable (bundled) |
Key Code-Family Distinctions (High Yield)
| Code | What It Is | Indwelling? | Complexity |
|---|---|---|---|
| 51701 | Intermittent (straight) catheterization | ❌ No — catheter removed after drainage | N/A |
| 51702 | Indwelling catheter insertion; simple | ✅ Yes — Foley left in place | Routine, no extra technique |
| 51703 | Indwelling catheter insertion; complicated | ✅ Yes — Foley left in place | Extra work: coudé, guidewire, altered anatomy, fractured device |
Tip
Documentation Requirements
Minimum documentation (what auditors look for)
- Medical necessity for indwelling catheter (e.g., acute urinary retention, post-operative I&O monitoring, neurogenic bladder, obstruction)
- That the insertion was simple/straightforward (explicitly state “without difficulty” or “routine placement”)
- Catheter details: size (e.g., 16 Fr), balloon volume (e.g., 10 mL), brand if relevant
- Return of urine confirmed (volume, color, clarity)
- Catheter secured and patient tolerated the procedure
Suggested phrasing
“A 16 Fr 2-way Foley catheter was inserted without difficulty in a single attempt. 10 mL saline inflated the balloon, 200 mL clear yellow urine returned. Catheter secured to thigh. Patient voided spontaneously [or] tolerated well.”
Red flags that suggest 51703 instead
- “Required coudé catheter”
- “Multiple attempts needed”
- “Placed under fluoroscopic guidance”
- “Used guidewire to navigate stricture”
- “Altered anatomy due to prior prostatectomy”
- “Fractured balloon encountered”
Medicare Rules & Bundling
NCCI Bundling Policy (Critical)
Per CMS NCCI policy, CPT 51701–51703 shall not be reported with any procedure carrying a global period of 000, 010, or 090 days. The catheter insertion is considered part of the global surgical package.
| Scenario | Reportable? | Reason |
|---|---|---|
| 51702 alone in office (urinary retention) | âś… Yes | Standalone, 0-day global |
| 51702 alone in ED (retention) | âś… Yes | Standalone, 0-day global |
| 51702 on same day as a 90-day global surgery | ❌ No | Bundled into the surgical global package |
| 51702 + E/M same day (minor procedure) | E/M with -25 | 51702 has 0-day global; E/M separately reportable with -25 |
| 51702 + E/M same day (major surgery decision) | E/M with -57 | Decision for surgery is separately reportable |
Global Period
000 — Zero-Day Global
- No pre-op or post-op days bundled
- The code covers only the date of service
- Follow-up visits are separately billable
- Global period modifiers (-54, -55, -56) are not applicable
Work RVU & Fee Schedule (2026)
| RVU Component | Value | What It Represents |
|---|---|---|
| Work RVU | 0.49 | Physician work, cognitive effort, time at bedside |
| Practice Expense (non-facility) | ~0.35 | Catheter supply, sterile kit, nursing assist |
| Practice Expense (facility) | ~0.14 | Reduced — hospital/ASC provides equipment |
| Malpractice RVU | ~0.04 | Professional liability |
| Total (non-facility) | ~0.88 | |
| Total (facility) | ~0.67 |
Common ICD-10-CM Pairings
| ICD-10 | Description | When to Use |
|---|---|---|
| R33.9 | Retention of urine, unspecified | Most common — acute retention |
| N40.1 | BPH with lower urinary tract symptoms | Male patient, obstructive etiology |
| N39.0 | UTI, site not specified | Catheterized for UTI management |
| N31.9 | Neuromuscular dysfunction of bladder, unspecified | Neurogenic bladder |
| Z93.0 | Presence of bladder catheter | Follow-up visits with catheter in situ |
| R39.0 | Acute kidney failure (if obstructive uropathy) | Post-obstructive, bilateral |
Common Modifiers
| Modifier | When Applicable | Notes |
|---|---|---|
| -25 | Same-day E/M with 51702 | Apply to the E/M code, not 51702 |
| -59 | Distinct procedural service | Only if truly separate from another procedure; verify payer policy |
| -53 | Discontinued procedure | If insertion was attempted but not completed |
Tip
Related Codes (Cross-Reference)
| Code | Relationship |
|---|---|
| 51701 | Intermittent (straight) catheterization — NOT indwelling |
| 51703 | Complicated indwelling catheter — extra technique required |
| 51705 | Removal of ureteral catheter or stent |
| 51706 | Removal of bladder catheter (simple) |
| 52000 | Cystoscopy (diagnostic) — endoscopic |
| 52295 | Insertion of permanent indwelling catheter (suprapubic) |
Coding Pitfalls & Audit Traps
| Pitfall | Correct Action |
|---|---|
| Billing 51702 when a coudé catheter was used | Use 51703 |
| Billing 51702 with a 90-day global surgery | Do not bill — bundled |
| Billing 51702 for a straight cath (intermittent) | Use 51701 |
| Billing 51702 + 52000 (cystoscopy) same day without -59 | Verify NCCI edits; likely bundled |
| Documenting “difficult” but billing 51702 | Re-code to 51703 with supporting documentation |
| Using 51702 for catheter exchange | Generally not separately reportable (included in monitoring) |
DOCUMENTATION REQUIREMENTS FOR 51702
Minimum Documentation Components
Indication/History:
- Chief Complaint: “Ureteral obstruction,” “hematuria,” “stone retrieval,” etc.
- History of Present Illness: Onset, duration, imaging findings (CT, ultrasound), prior treatment
- Relevant PMH: Prior ureteral obstruction, stones, strictures, malignancy
- Imaging Results: CT/ultrasound findings supporting need for catheterization
Procedure Description:
- Position: lithotomy or supine
- Anesthesia: Topical (urethral jelly), local anesthesia, sedation, or general; dose documented
- Instrumentation: Type of catheter(s) used (feeding tube, catheter type/size), presence of guide wire
- Approach: Blind retrograde, fluoroscopic-guided, digital palpation
- Fluoroscopy: Note if fluoroscopy used (for billing purposes and radiation dose documentation)
- Bilateral vs. Unilateral: Which ureter(s) accessed
Findings/Results:
- Ureteral Access: Successfully accessed; difficulty encountered
- Obstruction Status: Obstruction identified; location (proximal, mid, distal ureter)
- Obstruction Relief: Partial, complete, or unsuccessful relief achieved
- Specimen Collection: If biopsy, brushings, or washings obtained
- Catheter Placement: Catheter successfully placed; catheter position (distal ureter, renal pelvis)
- Contrast Administration: If diagnostic imaging performed, findings noted
- Complications: Perforation, bleeding, infection, other adverse events
Assessment/Impression:
- Procedure Success: “Successfully performed,” “partially successful,” “unsuccessful”
- Finding: “Right ureteral obstruction due to stone,” “Left ureteral stricture,” etc.
- Outcome: Obstruction relieved, catheter placed, specimen obtained
Plan:
- Catheter Management: catheter left in place or removed; duration if left in place
- Stent Placement: If stent placed (note if separate code CPT 50688, 50690, etc.)
- Follow-up: Return to clinic, imaging studies, urology follow-up, etc.
- Imaging: If retrograde pyelography performed, radiographic findings documented
Fluoroscopy Documentation (if applicable):
- Note use of fluoroscopy/X-ray guidance
- Number of images obtained
- Radiation dose (if available)
- Radiologic report, if separate
- Consider billing CPT 76000-76001 (fluoroscopy supervision and interpretation) if not included
BUNDLING RULES (CRITICAL)
⚠️ IMPORTANT: CPT 51702 is frequently bundled with cystoscopy (52000) and/or other endoscopic procedures.
Common Bundling Scenarios
| Scenario | Bundling Status | Notes |
|---|---|---|
| 51702 alone | Non-bundled | Standalone catheterization, no cystoscopy |
| 51702 + 52000 (cystoscopy) | BUNDLED | Usually included in 52000 when performed together |
| 51702 + 52204 (cystoscopy + fulguration) | BUNDLED | Usually included in the cystoscopy code |
| 51702 + 52282 (cystoscopy + ureteroscopy) | BUNDLED/INCLUDED | May be included in ureteroscopy code |
| 51702 + stent placement (50688/50690) | SEPARATE | Stent codes are separate; catheterization may still be bundled with cystoscopy if performed endoscopically |
⚠️ WARNING:
When 51702 Is Separately Billable
- Standalone non-endoscopic catheterization - No cystoscope used, pure blind retrograde catheterization
- Non-endoscopic catheterization without concurrent endoscopic procedure - E.g., office-based catheterization for diagnostic retrograde pyelography
- When unbundled by payer - Some payers may allow separate billing with appropriate modifier (-59)
MEDICARE RULES FOR 51702
CMS-Specific Rules & Policies
1. Bundling with Cystoscopy (52000)
- Many Medicare Administrative Contractors (MACs) bundle 51702 when performed with cystoscopy (52000 series)
- If performing non-endoscopic catheterization WITHOUT cystoscopy, 51702 is separately billable
- Verify your MAC’s bundling policy in their LCD
2. Bundling with Ureteroscopy (52351-52352)
- Retrograde ureteral catheterization performed during ureteroscopy may be included in the ureteroscopy code
- If separate ureteral catheterization outside of ureteroscopy, may be separately billable
3. Fluoroscopy Billing
- If fluoroscopy used for guidance, verify whether fluoroscopy is included in 51702 RVU or billed separately
- CPT 76000-76001 (fluoroscopy supervision and interpretation) may be separately billable
- Check payer policy; many include fluoroscopy in procedure RVU
4. Same-Day E/M Billing
- Can bill E/M with modifier -25 on same day as 51702
- E/M must be separately identifiable (not routine to procedure)
- Example: 99213-25 (E/M for hematuria) + 51702 (ureteral catheterization)
5. Stent Placement Coding
- If stent placed during catheterization, use additional code:
- Do NOT use 51702 + stent code if endoscopic approach used; use ureteroscopy code instead
6. RHC/FQHC Considerations
- RHCs/FQHCs may bill 51702 but payment goes to facility’s all-inclusive rate
- Individual provider cannot bill separately if employed by RHC/FQHC
LOCAL COVERAGE DETERMINATIONS (LCDs) & NATIONAL COVERAGE
National Coverage Determination (NCD)
There is NO specific NCD for CPT 51702.
General Medicare Coverage Policy:
- Catheterization of ureters for relief of obstruction or diagnostic purposes covered when medically necessary
- Must be appropriate based on patient’s presenting condition and imaging findings
- No frequency limitations per Medicare statute (must be medically necessary)
Local Coverage Determinations (LCDs) - MAC-Specific
LCDs vary by Medicare Administrative Contractor (MAC) jurisdiction.
Common LCD Issues for 51702:
| Requirement | Details |
|---|---|
| Bundling Status | Critical—many MACs bundle with cystoscopy (52000); verify before billing |
| Medical Necessity | Must have documented obstructive uropathy or diagnostic indication |
| Documentation | Procedure note must include findings (obstruction location, relief achieved, etc.) |
| Diagnosis Code | ICD-10 must support indication (N13.1 ureteral obstruction, N20 stone, etc.) |
| Fluoroscopy | Verify whether fluoroscopy is included or separately billable |
| Stent Coding | If stent placed, use appropriate stent code (50688 or 50690) in addition |
| Provider Credentials | Urologist or licensed provider with appropriate credentials |
To Find Your MAC’s LCD:
- Go to CMS LCD Search Tool: https://www.cms.gov/cclc/lcd
- Enter your MAC jurisdiction
- Search for “ureteral catheterization” or “retrograde catheterization”
- Review bundling rules and coverage requirements
COMPARISON TO RELATED CODES
Ureteral Catheterization Code Family
| Code | Description | RVU | Approach | Use Case |
|---|---|---|---|---|
| 51702 | Catheterization, ureteral, non-endoscopic (retrograde) | 0.47 work | Blind retrograde | Relief of obstruction, diagnostic retrograde pyelography |
| 52005 | cystourethroscopy with ureteral catheterization | 0.67 work | Endoscopic (with cystoscope) | Visualization + catheterization for obstruction relief |
| 50382 | Percutaneous ureteral catheterization | 1.04 work | Percutaneous (flank) | Direct renal access; alternative to retrograde approach |
| 50688 | Ureteral stent placement, transurethral | 0.70 work | Endoscopic retrograde | Stent placement (additional code) |
| 50690 | Ureteral stent placement, percutaneous | 0.88 work | Percutaneous | Stent placement via percutaneous approach |
51702 vs 52005 (Catheterization Approaches)
| Aspect | 51702 (Non-Endoscopic) | 52005 (Endoscopic) |
|---|---|---|
| Visualization | Blind retrograde or fluoroscopic guidance | Direct visualization with cystoscope |
| Approach | Transurethral, no scope | Transurethral, with scope (52000 included) |
| RVU (Work) | 0.47 | 0.67 |
| Bundling | Often bundled with 52000 if same session | Includes cystoscopy |
| Indication | Obstruction relief, diagnostic, when scope not needed | Direct visualization preferred, obstruction relief |
| Advantages | Simpler, no scope; can be office-based | Better visualization; direct assessment of bladder/urethra |
| Disadvantages | Blind approach; less visualization; may be bundled | Requires scope; more invasive |
FREQUENTLY BILLED SCENARIOS FOR 51702
Scenario 1: Retrograde Relief of Ureteral Stone Obstruction
Patient: 54-year-old with right flank pain and CT-confirmed right ureteral stone
Imaging: CT shows right mid-ureteral stone with proximal hydronephrosis
Indication: Retrograde relief of ureteral stone obstruction
Procedure: Patient positioned supine, draped sterile. Retrograde ureteral catheterization performed under fluoroscopic guidance. Catheter advanced blindly through urethra, past ureteropelvic junction into right proximal ureter above stone. Contrast injected retrograde; stone confirmed at mid-ureter. Catheter left in place as ureteral stent for drainage and pain relief.
Findings: Right ureteral stone at mid-ureter confirmed on retrograde pyelography. Successful catheter placement above obstruction.
Plan: Catheter left in place. Patient to follow up with urology for definitive stone management ureteroscopy and stone extraction.
Coding:
- 51702 (ureteral catheterization, non-endoscopic)
- 50688 (ureteral stent placement, transurethral) - if stent left as separate billable service
- 76000 or 76001 (fluoroscopy) - if not bundled in 51702
- Diagnosis: N20.1 (ureteral stone), N13.2 (hydronephrosis, secondary)
Scenario 2: Diagnostic Retrograde Pyelography for Ureteral Stricture
Patient: 68-year-old with history of prior pelvic surgery, now with recurrent UTI and left flank pain
Imaging: Ultrasound shows left hydronephrosis; stone ruled out
Indication: Diagnostic retrograde pyelography to assess for stricture
Procedure: Retrograde ureteral catheterization performed blindly using fluoroscopic guidance. Catheter advanced into left ureter. Contrast injected; stricture identified at distal left ureter post-pelvic surgery.
Findings: Left distal ureteral stricture confirmed on retrograde pyelography. No immediate intervention performed; patient counseled on options.
Plan: Refer to urology for endoscopic or percutaneous intervention. Possible stent placement or dilation.
Coding:
- 51702 (ureteral catheterization, non-endoscopic)
- 76000 or 76001 (fluoroscopy, if separate)
- Diagnosis: N13.0 (ureteral stricture), N13.2 (hydronephrosis, secondary), Z12.81 (history of pelvic surgery)
Scenario 3: Retrograde Ureteral Catheterization with Specimen Collection
Patient: 72-year-old with hematuria and imaging suggesting ureteral mass
Imaging: CT shows possible ureteral lesion, left proximal ureter
Indication: Diagnostic catheterization with brushing/specimen collection for cytology
Procedure: Retrograde ureteral catheterization performed. Catheter advanced to left proximal ureter. Brush catheter passed through for brushing of lesion; specimens obtained for cytopathology.
Findings: Ureteral lesion visualized; brushings obtained. Cytology pending.
Plan: Await cytology results. If malignancy confirmed, refer for endourology or oncology consultation.
Coding:
- 51702 (ureteral catheterization, non-endoscopic)
- 52007 (cystourethroscopy with brush biopsy of ureteral/renal pelvis lesion) - if endoscopic approach used instead
- Diagnosis: R31.9 (hematuria, unspecified), N13.1 (hydronephrosis with ureteral obstruction, unspecified)
Scenario 4: Retrograde Catheterization During Cystoscopy (Bundling Issue)
Patient: 58-year-old with gross hematuria and imaging showing bladder mass and right ureteral obstruction
Procedure: Cystoscopy performed for bladder evaluation. During cystoscopy, retrograde ureteral catheterization performed to relieve right ureteral obstruction due to extrinsic compression from bladder tumor.
Findings: Bladder tumor noted on cystoscopy. Right ureteral obstruction relieved with catheterization.
Plan: Ureteral stent placement. Oncology referral for bladder tumor.
Coding (Verify payer bundling):
- 52000 or 52204 (cystoscopy, with or without fulguration)
- 51702 - May be bundled with cystoscopy; verify if separately billable
- If separately billable: Add 51702-59 (distinct procedural service)
- If bundled: Do NOT bill 51702 separately
- 50688 (ureteral stent placement) - Separately billable
- Diagnosis: C67.9 (bladder cancer), N13.1 (ureteral obstruction)
- ⚠️ WARNING: Pre-authorization recommended due to bundling uncertainty
DOCUMENTATION TIPS FOR 51702
What to Document
âś“ SHOULD INCLUDE:
- Procedure Indication - Obstruction relief, diagnostic imaging, specimen collection, etc.
- Imaging Results - CT/ultrasound findings supporting need for catheterization
- Patient Position - lithotomy, supine, other
- Anesthesia - Type (topical, local, sedation, general), dosage
- Approach - Blind retrograde, fluoroscopic-guided, digital palpation
- Instrumentation - Catheter type and size, guide wire use, number of attempts
- Fluoroscopy - Note if used; document fluoroscopy time/dose if available
- Bilateral vs. Unilateral - Which ureter(s) catheterized
- Ureteral Access - Successfully accessed, attempts required, any difficulty
- Obstruction Assessment:
- Location: Proximal, mid, or distal ureter
- Cause: stone, stricture, mass, clot, other
- Relief: Partial, complete, or unsuccessful obstruction relief
- Catheter Placement: Final position, catheter left in place or removed
- Specimen Collection: If obtained (brushings, washings, biopsy); note specimens sent
- Contrast Administration: If retrograde pyelography performed; findings documented
- Complications: Perforation, bleeding, infection, other adverse events
- Post-Procedure Plan - Follow-up, stent management, definitive treatment planning
- Provider Signature/Authentication - Date, time, credentials
âś— SHOULD AVOID:
- Vague findings (“procedure successful” without detail on location or relief achieved)
- Missing obstruction location or characteristics
- No documentation of which ureter(s) catheterized (especially important for bilateral procedures)
- Copy-paste from previous notes without updating for current procedure
- Missing fluoroscopy documentation if performed
- No assessment of whether obstruction was relieved
Sample Documentation Format
Procedure Note - Retrograde Ureteral Catheterization (51702)
INDICATION:
Patient presents with right flank pain and CT findings of right mid-ureteral stone with proximal hydronephrosis and elevated creatinine. Retrograde ureteral catheterization performed for relief of Obstructive uropathy.
PROCEDURE:
Patient placed in supine position and prepped and draped in sterile fashion. Digital rectal examination performed to assess prostate size and patency. Retrograde approach selected due to stone location. Retrograde ureteral catheterization performed under fluoroscopic guidance using a 7 Fr open-ended ureteral catheter. Catheter advanced blindly through urethra, past ureteropelvic junction into right proximal ureter. Contrast (30 mL Visipaque) injected retrograde for diagnostic imaging.
FINDINGS:
Obstruction Location: Right mid-ureteral stone, approximately 1.2 cm, confirmed on retrograde pyelography.
Catheter Placement: 7 Fr catheter successfully advanced to right proximal ureter, proximal to stone obstruction. Final catheter position: right proximal ureter at level of L2 vertebra.
Obstruction Relief: Complete relief of obstruction achieved. Retrograde flow of contrast into renal pelvis and calices; no hydronephrosis noted on immediate post-catheterization images. Catheter patent with free flow of urine/contrast.
Fluoroscopy: Fluoroscopic guidance used throughout procedure. Approximately 8 fluoroscopic images obtained. Estimated radiation dose: 0.5 mGy.
Complications: None.
ASSESSMENT:
Successful retrograde ureteral catheterization with relief of right ureteral stone obstruction.
PLAN:
- Ureteral catheter left in place as temporary stent for pain relief and drainage.
- Patient discharged with catheter. Leg bag provided for drainage management at home.
- Patient counseled on signs of infection (fever, dysuria, purulent drainage) and instructed to return immediately if fever or severe pain develops.
- Follow-up appointment in 1 week with urology for definitive stone management (ureteroscopy and laser lithotripsy vs. percutaneous approach).
- Stent removal/replacement plan: Stent to remain in place for 1 week, then reassessed after stone treatment.
AUDIT DEFENSE CHECKLIST FOR 51702
Before billing 51702, verify:
- Medical necessity documented - Clear indication for catheterization (obstruction, diagnostic imaging, specimen collection)
- Imaging results documented - CT/ultrasound findings supporting obstruction or diagnostic need
- Obstruction location documented - Proximal, mid, or distal ureter
- Obstruction cause documented - Stone, stricture, mass, clot, or other
- Ureteral access successful - Note if catheter successfully passed into ureter
- Obstruction relief documented - Partial, complete, or unsuccessful relief achieved
- Bilateral vs. unilateral documented - Which ureter(s) catheterized
- Catheter placement documented - Final catheter position and status (left in place or removed)
- Fluoroscopy documented - If used for guidance; fluoroscopy code may be separately billable
- Specimen collection documented - If biopsies, brushings, or washings obtained
- Complications documented - If any (perforation, bleeding, infection)
- Plan documented - Follow-up, stent management, definitive treatment
- E/M code with -25 modifier (if billed same day) - If E/M billed with 51702, E/M must have -25 modifier
- Bundling verified - If cystoscopy performed same day, verify whether 51702 bundled or separately billable
- Proper modifiers used - -LT/-RT for side-specific; -59 if distinct from endoscopic procedure; -52 if reduced
- Diagnosis code(s) support procedure - ICD-10 codes justify catheterization indication
RED FLAGS FOR AUDITORS
51702 claims are at audit risk if:
- ❌ Medical necessity documentation missing or vague (“catheterization for hematuria evaluation” without imaging)
- ❌ Obstruction location or characteristics not documented
- ❌ Bilateral procedures coded as unilateral without specification (-RT/-LT missing)
- ❌ Billed with cystoscopy (52000) without verification of bundling rules (payer may deny 51702)
- ❌ Fluoroscopy used but not documented; no fluoroscopy code billed (if separately billable)
- ❌ Catheter left in place but no stent code (50688/50690) billed when appropriate
- ❌ Procedure appears routine/incomplete but documented as successful
- ❌ E/M billed same day without -25 modifier (may be bundled/denied)
- ❌ Specimen collection documented but no collection code (52007 if endoscopic approach) billed
- ❌ Documentation appears copy-pasted or generic without specific procedure details
MEDICARE RULES & RESTRICTIONS
Who Can Bill 51702?
Qualified Providers:
- MD/DO: Urologist, urogynecologist, general surgeon, internist, emergency medicine physician (with appropriate training)
- NP: Nurse Practitioner with urology or relevant specialty training
- PA: Physician Assistant in 00 Urology Specialty or with appropriate training
- Other specialists: May perform depending on scope of practice and state regulations
Licensing & Credentialing: Verify state regulations and facility/payer credentialing requirements.
RHC/FQHC Restrictions
If provider is employed by RHC or FQHC:
- 51702 is reportable but payment goes to facility’s All-Inclusive Rate (AIR) or Prospective Payment System (PPS)
- Individual provider cannot bill separately for 51702
- Facility receives bundled payment for all services that day
Telehealth Coverage for 51702
CPT 51702 via Telehealth:
- NOT reimbursable via telehealth because procedure requires direct patient contact and requires physical manipulation of catheter through urethra
- Telehealth consultations about catheterization results or planning = E/M code (99213, 50 Medical Coding/CPT Codes/99214, etc.), not 51702
Concurrent Billing Issues
Same-Day Billing with E/M:
- Can bill 51702 + E/M same day with modifier -25 on the E/M code
- E/M must be separately identifiable (not routine to procedure)
- Example: 99213-25 (E/M for hematuria) + 51702 (ureteral catheterization)
Same-Day Billing with Cystoscopy (52000):
- OFTEN BUNDLED - Verify payer policy before billing both
- If bundled: Do NOT bill 51702 separately
- If separately billable: Bill 51702-59 to indicate distinct procedural service
- Pre-authorization recommended due to bundling variability
COMPLIANCE & CODING EXAMPLES
Appropriate 51702 Use Cases âś“
- Retrograde relief of ureteral stone obstruction - Stone causing obstruction and pain; catheterization for relief
- Retrograde relief of ureteral stricture obstruction - Stricture causing hydronephrosis; catheterization for diagnostic imaging and relief
- Diagnostic retrograde pyelography - Evaluation of hematuria with possible ureteral pathology
- Specimen collection - Brushing, washing for cytology in suspected ureteral malignancy
- Retrograde ureteral catheterization for medication administration - Therapeutic intervention
- Retrograde catheterization to assess ureteral patency - Pre-operative evaluation
- Non-endoscopic catheterization for diagnostic purposes - When endoscopic approach not feasible
Inappropriate 51702 Use (Risks) âś—
- ❌ Billed with endoscopic cystoscopy without verification of bundling - May be bundled; payer may deny
- ❌ Billed for bilateral obstruction without bilateral modifier - 51702-LT and 51702-RT (or 51702-50) required
- ❌ Medical necessity documentation missing - No imaging or clinical justification documented
- ❌ Used instead of endoscopic catheterization (52005) without clear indication - Non-endoscopic approach should have justification
- ❌ Billed without stent code when stent placed - If stent placed, add 50688 or 50690
FREQUENTLY ASKED QUESTIONS (FAQs)
Q: When should I use 51702 instead of 52005 (endoscopic catheterization)?
A: 51702 is non-endoscopic (blind retrograde), useful when cystoscope not needed or not available. 52005 is endoscopic with cystoscopy. 52005 is preferred if direct visualization needed; 51702 is simpler but blind approach.
Q: Can I bill 51702 if I perform it during cystoscopy?
A: Typically NO. If catheterization performed during cystoscopy (with cystoscope), use 52005 or include in cystoscopy code (52000 series). 51702 is specifically for non-endoscopic approach. Verify payer bundling rules.
Q: Should I bill 51702 and 52005 for the same patient if I use both approaches (first blind, then endoscopic)?
A: Possibly, if clearly documented as two separate attempts with clinical justification. However, most payers would likely deny 51702 as bundled with 52005. Pre-authorization recommended.
Q: Can I bill 51702 if I place a ureteral stent?
A: Yes. 51702 is catheterization; 50688 or 50690 is stent placement. They are separate codes and can both be billed if both services performed.
Q: Is fluoroscopy included in 51702 reimbursement?
A: Partially. The 51702 RVU assumes some fluoroscopy guidance, but additional fluoroscopy (76000-76001 supervision and interpretation) may be separately billable. Verify payer policy.
Q: What if my retrograde catheterization attempt fails?
A: Document the attempt and failure reason. If procedure not completed, use modifier -52 (reduced services). Payer may pay reduced RVU amount.
Q: Can I bill 51702 for both right and left ureter in one procedure?
A: Yes. Use modifier -50 (bilateral) or bill two separate codes 51702-LT and 51702-RT. Check your payer’s preference; some require bilateral modifier, others require separate side-specific codes.
Q: Is 51702 bundled with routine cystoscopy (52000)?
A: Often YES. Many MACs bundle 51702 with 52000 when performed together. Some allow separate billing with modifier -59. Verify your MAC’s LCD before billing both.
REAL-WORLD BILLING TIPS
Tips to Maximize Compliance & Revenue
- Verify bundling rules FIRST - Check MAC LCD and payer policy before billing 51702 with cystoscopy
- Document obstruction specifics - Location (proximal/mid/distal), cause (stone/stricture/mass), relief achieved
- Use bilateral modifiers correctly - 51702-50 or 51702-LT + 51702-RT (verify payer preference)
- Link diagnosis to indication - ICD-10 codes should match catheterization reason
- Document imaging results - CT/ultrasound findings supporting need for catheterization
- Include fluoroscopy documentation - Note fluoroscopy use; verify if separately billable
- Use -25 with E/M same day - When E/M billed with 51702, apply -25 to E/M
- Pre-authorize bundling uncertainty - If billing 51702 + 52000, request pre-auth to avoid denial
- Document specimen collection separately - If biopsy/brushings obtained, note collection method and specimens obtained
- Keep procedure notes detailed - Specify catheter size, route, obstruction location, catheter placement, relief achieved
BILLING & CODING RESOURCES
Recommended Resources:
- AMA CPT Manual 2025 - Official CPT code definitions
- CMS Fee Schedule Database: https://www.cms.gov/medicare/physician-fee-schedule
- MAC LCDs: https://www.cms.gov/cclc/lcd (search for “ureteral catheterization”)
- American Urological Association (AUA): https://www.auanet.org (coding resources)
- Your payer’s provider manual - Payer-specific bundling rules
SUMMARY TABLE
| Element | Details |
|---|---|
| Official Definition | Catheterization, ureteral, non-endoscopic (retrograde) |
| Global Period | 000 (no bundled post-op) |
| Work RVU (2025) | 0.47 |
| Total RVU (2025, Non-Facility) | 0.90 |
| Medicare Payment (2025, Non-Facility) | ~$29.11 |
| Medicare Payment (2025, Facility) | ~$21.67 |
| Typical Time | 10-30 minutes |
| Provider Required | Yes (urologist, surgeon, or trained provider) |
| Common Modifiers | -LT/-RT (side-specific), -25 (with E/M), -59 (distinct from endoscopy), -50 (bilateral) |
| Typical Use | Obstruction relief, diagnostic imaging, specimen collection |
| Common Mistakes | Bundling with cystoscopy without verification; missing bilateral modifiers; inadequate documentation |
| Audit Risk | Moderate (bundling is main risk) |
| Bundling | Often bundled with cystoscopy (52000); verify payer policy |
| Telehealth Allowed | No (requires direct patient contact) |
Document Created: February 2026
Compliant with: 2021 AMA E/M Guidelines, 2025 Medicare Physician Fee Schedule, CMS NCCI Coding Policy Manual, Current Payer Policies
Last Updated: February 2026